Export Standby Letter of Credit

bank instruments

Export Standby Letter of Credit

SWITZERLAND, March 31, 2020 /EINPresswire.com/ — Standby Letter of Credit (SBLC) is a legal document that guarantees a bank's commitment of payment to a seller in the event that the buyer–or the bank's client–defaults on the agreement. The Standby Letter of Credit (SBLC) helps facilitate international trade between companies that don't know each other and have different laws and regulations. The Standby Letter of Credit can also be abbreviated SBLC.

How a Standby Letter of Credit (SBLC) Works : Standby Letter of Credit (SBLC) is most often sought by a business to help it obtain a contract. The contract is a "standby" agreement because the bank will have to pay only in a worst-case scenario. Although an SBLC guarantees payment to a seller, the agreement must be followed exactly.

There are two main types of Standby Letter of Credit (SBLC):

The Financial SBLC guarantees payment for goods or services as specified by an agreement. An oil refining company, for example, might arrange for such a letter to reassure a seller of crude oil that it can pay for a huge delivery of crude oil.

The performance SBLC , which is less common, guarantees that the client will complete the project outlined in a contract. The bank agrees to reimburse the third party in the event that its client fails to complete the project.

Benefits Standby Letter of Credit (SBLC):

▪ The Standby Letter of Credit (SBLC) is often seen in contracts involving international trade, which tend to involve a large commitment of money and have added risks.

▪ Avoid or secure advance payment.

▪ Obtain Credit.

▪ Secure compensation for non-fulfillment of important obligation.

▪ The banks involved will act according to the internationally accepted rules of the International Chamber of Commerce.

Common Use of Standby Letter of Credit (SBLC)- Advance payment guarantees – Payment guarantees – Performance guarantees.

Security in Foreign Trading:

Offer your trading partner a Standby Letter of Credit (SBLC) to secure the fulfillment of your company's obligations under the agreement. This way your trading partner knows that you are a reliable cooperation partner.

Use Standby Letter of Credit (SBLC) for managing foreign trade risks.

Jan Kater
RA Solar Technologie Investment GmbH
+41 615087389
email us here
Visit us on social media:

Source: EIN Presswire

Nuclear Waste Management System Market 2020 Global Trend, Segmentation and Opportunities, Forecast 2025

Nuclear Waste Management System -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025

PUNE, MAHARASHTRA, INDIA, March 31, 2020 /EINPresswire.com/ — Nuclear Waste Management System Industry


he report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Nuclear Waste Management System by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):=

Areva SA
Veolia Environment Services
Bechtel Corporation
US Ecology
Augean Plc
BHI Energy
Perma-Fix Environmental Services, Inc.
Swedish Nuclear Fuel and Waste Management Co.
Stericycle, Inc.
Waste Control Specialists, LLC

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/4968631-global-nuclear-waste-management-system-market-analysis-2015

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Low Level Waste
Intermediate Level Waste
High Level Waste

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Boiling Water Reactors
Gas Cooled Reactors
Pressurized Water Reactors
Pressurized Heavy Water Reactors

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)

Leave a Query @ https://www.wiseguyreports.com/enquiry/4968631-global-nuclear-waste-management-system-market-analysis-2015

Table of Content

1 Industry Overview
1.1 Nuclear Waste Management System Industry
Figure Nuclear Waste Management System Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Nuclear Waste Management System
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Nuclear Waste Management System
1.2.2 Downstream
Table Application Segment of Nuclear Waste Management System
Table Global Nuclear Waste Management System Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis

2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology


4 Major Companies List
4.1 Areva SA (Company Profile, Sales Data etc.)
4.1.1 Areva SA Profile
Table Areva SA Overview List
4.1.2 Areva SA Products & Services
4.1.3 Areva SA Business Operation Conditions
Table Business Operation of Areva SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Veolia Environment Services (Company Profile, Sales Data etc.)
4.2.1 Veolia Environment Services Profile
Table Veolia Environment Services Overview List
4.2.2 Veolia Environment Services Products & Services
4.2.3 Veolia Environment Services Business Operation Conditions
Table Business Operation of Veolia Environment Services (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Bechtel Corporation (Company Profile, Sales Data etc.)
4.3.1 Bechtel Corporation Profile
Table Bechtel Corporation Overview List
4.3.2 Bechtel Corporation Products & Services
4.3.3 Bechtel Corporation Business Operation Conditions
Table Business Operation of Bechtel Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 US Ecology (Company Profile, Sales Data etc.)
4.4.1 US Ecology Profile
Table US Ecology Overview List
4.4.2 US Ecology Products & Services
4.4.3 US Ecology Business Operation Conditions
Table Business Operation of US Ecology (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Augean Plc (Company Profile, Sales Data etc.)
4.6 BHI Energy (Company Profile, Sales Data etc.)
4.7 Perma-Fix Environmental Services, Inc. (Company Profile, Sales Data etc.)
4.8 Swedish Nuclear Fuel and Waste Management Co. (Company Profile, Sales Data etc.)
4.9 Stericycle, Inc. (Company Profile, Sales Data etc.)
4.10 Waste Control Specialists, LLC (Company Profile, Sales Data etc.)

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=4968631


Contact Us: Sales@Wiseguyreports.com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

email us here

Source: EIN Presswire

Creative ways one mom has stepped up to help neighbors, community and restaurants due to Covid-19 pandemic

Bonnie and Patrick Kearns and family

Sarah Stegner, co-owner and co-chef, Prairie Grass Cafe in Northbrook IL

Prairie Grass Cafe logo

Bonnie Kearns didn’t want to feel helpless. Knowing that her neighborhood was homebound with concerns of the Corona Covid 19 virus, she kicked into action.

GLENVIEW, IL, UNITED STATES, March 30, 2020 /EINPresswire.com/ — Bonnie Kearns of Glenview IL is extraordinary. She didn’t want to feel helpless and knowing that her neighborhood was homebound with concerns of the Corona Covid 19 virus, she kicked into action.

“It takes a village. It really does. Our little block in Glenview is just one component in the quarantine,” she said in a recent interview.

In efforts to curb the spread of COVID-19, moms have been texting each about limited trips to the grocery store. Every other day, someone "takes one for the team" and makes the dreaded trip. “Asking everyone if they need anything, deliveries are dropped off on porches in plastic bags and we send a quick text that food and paper towels have arrived.”

We're relieved we don't have to face the impending doom of touching doors, credit card machines, carts, anything outside of our control for just another day.

Our new normal:
• Cooking every meal became exhausting quickly. It is difficult to figure out what to make. “I felt like a failure,” says Bonnie. I was staring at a box of Mac & Cheese and felt like raising a flag in defeat. Then I received an email from Prairie Grass Cafe regarding curbside pickup and Sarah Stegner's cooking tip hotline, 847-920-8437 and Rohit Nambiar's selection of delicious reasonably priced wines to complement the food. Since I knew the neighborhood was suffering, I decided I would order food and wine for my neighbors who weren’t comfortable leaving their homes. I texted moms to take a break from cooking tomorrow and that we would have pot roast and wine delivered to their doors with Clorox-wiped delivery boxes. This snowballed with other opportunities to help.

• Sarah Stegner said "after I got her call, things started to come together for us. I thought it was a great model for how we could sell in large quantities. I thought, wow, I have to let other restaurateurs know to think outside the box to help make curbside and delivery viable. People are picking up for their neighborhoods, too. This may be a solution. We have also added to a neighborhood in Evanston IL and are going to add a couple of high rise buildings in Chicago."

• Bonnie continued: "I knew that medical professionals and first responders desperately needed help. A mom in our Facebook group mentioned that he was trying to boost morale in his office and ordered his employee’s lunch. After reading it twice, I realized it was my pediatrician's office. I was feeling helpless seeking ways I could provide relief to people that so desperately needed it. Bingo. I knew I could order wine from Prairie Grass and have it delivered to their office for the staff. That's what I plan to do. I also plan to order lunch from our neighborhood deli and have it dropped off."

• I had planned a surprise birthday party for my husband at Chicago’s Kaiser Tiger in the West Loop on Saturday, March 14. Obviously, we had to cancel the 40-person dinner with less than a day’s notice. It made me sick to know that servers were depending on the income and the loss to the restaurant would be great. I didn’t care about the deposits or what I was going to be charged; it became so apparent that people weren’t going to be celebrating anything anytime soon. The event planner was completely understanding. The next day, Governor Pritzker issued the stay at home order. After receiving the Prairie Grass Cafe email, I immediately figured out what I could do to help Kaiser Tiger and the people in their area. “Surely, the EMTs, firefighters, urgent care workers, and hospitals in the West Loop had people that needed to eat. Since I have no idea when we would be able to reschedule the party, I asked the restaurant to use the money for a better, more worthwhile cause and did not ask for a refund, said Bonnie.

Other suggestions from Bonnie:
• Larger businesses and their customers that can afford to forgo their event deposits could use the money towards a greater cause.

o Catering contracts for events that are happening in the next 1-3 months likely had 50% or more of the costs already due and are non-refundable.

o We can creatively rethink how that lost deposit can be used for other things – a credit to that restaurant in gift cards, catered lunch or meals for the less fortunate or neighborhood hospitals, doctors' offices, fire departments and other essential businesses that are staying open during this time. Anything to let these restaurants keep that revenue and perhaps put it towards the people that need it now. Not in 5 months. Now.

Cindy Kurman
+1 312-651-9000
email us here
Visit us on social media:

Source: EIN Presswire


The Flag and General Officers Network


Organization of 1,500 senior military leaders offers advice and support.

Like so many brave men and women who don the cloth of our nation, our members have endured numerous crises throughout their long military careers”

— Robert Wray, President of TFGON

WASHINGTON, D.C., UNITED STATES, March 30, 2020 /EINPresswire.com/ — The Flag and General Officers Network (TFGON), representing 1,500 generals and admirals from all the nations uniformed services, today issued the following statement on the current COVID-19 crisis:

We, an organization representing 1,500 retired generals and admirals of the US Uniformed Services, with some 50,000 years of service to our Nation, want to pass the following to our fellow citizens:

First, take this ongoing crisis very seriously, and do your part to adhere to the public health rules and recommendations being promulgated by our civilian leadership. Wash your hands. Practice social distancing. Stay home. Don't hoard supplies. Stay informed. ( www.cdc.gov/coronavirus )

Second, do more than your mere duty as a citizen. Volunteer. Innovate. Donate to reputable charities. Give blood. Call those seniors or disabled who are isolated at home. Deliver supplies to those in need. Step up– do what Americans have always done in times of crisis.

Third, we, the members of The Flag and General Officers Network, spread out all across America, are standing by to do our part, as best we can, to provide help in our respective communities. If we can support response efforts in any way, we're ready.

Finally, having endured and served through daunting crises both here and abroad, we have full faith and confidence that we as a Nation will persevere, and that this crisis too will pass."

“Like so many brave men and women who don the cloth of our nation, our members have endured numerous crises throughout their long military careers,” said Robert Wray, President of TFGON, and a retired Navy Rear Admiral. “We understand that we are but one small voice in this national conversation. But we want to assure our fellow citizens that, while COVID-19 has presented us with an unprecedented challenge, we as a nation will be okay, and that we’ll get through it together.”

[The Flag and General Officers Network is a non-profit, apolitical 501(c)(19) War Veterans Organization, based in Washington DC. Its membership is comprised of approximately 1,500 generals and admirals from the Army, Navy, Air Force, Marine Corps, National Oceanic and Atmospheric Administration (NOAA), and the United States Public Health Service, most of whom are retired from active duty.]


If you would like more information, please contact Admiral Wray at 401-474-7079, or e-mail president@flagandgeneralofficers.org, or visit our website, www.flagandgeneralofficers.org.

Robert Wray
The Flag and General Officers' Network
+1 401-474-7079
email us here
Visit us on social media:

Source: EIN Presswire

SUAOKI Launched new large-capacity portable power supply "S370"-the first USB Type-C I/O compatible, with 14 ports

SUAOKI S370 Image

SUAOKI S370 Image

SUAOKI S370 Image 2

SUAOKI S370 Image 2

SUAOKI S370 image 3

SUAOKI S370 image 3

The newly released S370 was born in a new outfit with upgrade function as an upgraded model of the S270, which is hot sale more than two years after its release

LOS ANELES, CALIFORNIA, UNITED STATES, March 30, 2020 /EINPresswire.com/ — On December 6, 2019, SUAOKI, a portable power supply brand, launched the S370, a new high-capacity portable power supply product that plays an active role in outdoor and disaster situations.

The newly released S370 was born in a new outfit with upgrade functionality as an upgraded model of the S270 series, which is still very popular, more than two years after its release.

“S370” is currently available at the following stores:
[Sales Price] 349.99 USD
SUAOKI Official Site: https://suaoki.com/suaoki-portable-power-station-322wh-generator/sk_1826266_027969211332.html
Amazon: https://www.amazon.com/dp/B0843WDXFQ/

* We are offering products for media/Youtuber introduction articles/video creation. Please contact affiliate@suaoki.com.

[Main features of the new product S370]
・ The market's first USB Type-C output-input support, charging convenience and speed are greatly improved
-Equipped with 14 spare ports, convenient for simultaneous charging of many electrical appliances
-322Wh large capacity but compact and stylish

Supports both USB Type-C output inputs for the first time on the market, greatly improving charging convenience and speed

The biggest feature of the new model “S370” is that it has the first slot for both USB Type-C output and input on the market. It supports a wide range of USB-C compatible devices such as notebook PCs, Android devices, iPhone / iPad, and Nintendo Switch, and can be charged at full speed with a maximum output of 60W.

Since the input is also compatible with PD, the charging method has been increased to 4WAYS. In addition to using conventional AC adapters, cigar sockets, and solar charging, there is no need to worry about being unable to charge the main unit with various charging methods.

Equipped with 14 spare ports, convenient for simultaneous charging of many electrical appliances

AC output (4 ports), DC output (4 ports), USB output (4 ports), Type-C output (1 port), cigar socket output (1 port), a total of 14 output ports, TV, electric blanket Many electric appliances such as in-car rice cookers, notebook PCs and smartphones can be charged at the same time.

322Wh Large capacity but compact and stylish

The S370, which has twice the capacity (322Wh) of the popular product "S270" in the series, has a compact size (24.5 x 15 x 14.5cm) that won't get in the way. With a storage handle, you can easily take it outdoors.

Also, it inherits the classic design style of “S270” red x black, and it becomes an urban outdoor style with added stylishness.

S370 is packed with other useful functions
・ With LED light: Switching between high-intensity lighting mode and SOS lighting mode is useful for work in places where there is no light or in emergencies.
-Sine wave output: Can be used with precision machines (such as ventilators) and microcomputer-controlled electrical products (such as electric blankets).

Detailed information on the new product "S370" can be found at the following store:
SUAOKI Official Site: https://suaoki.com/suaoki-portable-power-station-322wh-generator/sk_1826266_027969211332.html
Amazon: https://www.amazon.com/dp/B0843WDXFQ/
* We are offering products for media / Youtuber introduction articles/video creation. Please contact affiliate@suaoki.com.

The SUAOKI brand was born in 2015. We plan and produce and sell portable power supplies, solar power generators (solar panel chargers), car accessories, and outdoor equipment. The large-capacity portable power supplies S270 and G500, and the new product G1000, are very popular in Japan, Europe, and the United States.

We always strive for strict management in the manufacturing process and make every effort to ensure product quality. SUAOKI's goal is to deliver products with higher cost performance and to help everyone in outdoor activities and disaster prevention.

Official site: https://www.suaoki.com/
Official direct shop:
[Amazon: SUAOKI]:https://www.amazon.com/stores/node/12092702011

Official Facebook: https://www.facebook.com/suaokiofficial/
Official Comunity: https://www.facebook.com/groups/SuaokiFans
Official Twitter: https://twitter.com/suaoki_official
Official Instagram: https://www.instagram.com/suaoki_official

Bruce Li
+86 135 6030 2295
email us here

Source: EIN Presswire

Servants of The Holy Family in Colorado Springs begins online streaming of Mass during Coronavirus Outbreak

Traditional Latin Mass offered to Americans via online streaming.

COLORADO SPRINGS, COLORADO, USA, March 30, 2020 /EINPresswire.com/ — Servants of The Holy Family on Colorado Springs will begin streaming Mass online due to Corona virus and restrictions on large gatherings.

The order has assembled ebooks pertaining to Lent so followers will have spiritual reading during this period.

Viewers will be able to attend mass and visit the chapel virtually during this time.

Time schedule can be found at www.servi.org

All are welcome. There are no fees required.

Michael McMahon
Servants of The Holy Family
+1 7199854129
email us here

Source: EIN Presswire

Statement on the Passing of Senator Coburn

CONTACT: Anne Di Gregory
March 30, 2020 communications@menshealthnetwork.org
(202) 543-6461 ext. 101

Statement on the Passing of Senator Tom Coburn

WASHINGTON – Men’s Health Network (MHN) wishes to acknowledge with sadness the recent passing of Senator Tom Coburn (R-Oklahoma) following a long and brave battle with cancer. Sen. Coburn, during his long and accomplished tenure representing the Great State of Oklahoma in the U.S. House of Representatives and the U.S. Senate, distinguished himself as a strong proponent of fiscal responsibility.

As a physician, he also was eloquent, tireless and effective in his efforts and advocacy to ensure that patients received the health care they needed, and deserved.

"Senator Coburn's skill and dedication will be missed by all Americans, particularly by his fellow healthcare professionals. The boys, men, and families of America have lost a strong advocate," said Dr. Salvatore J. Giorgianni, Jr., Senior Science Advisor, Men's Health Network.

On behalf of MHN’s staff, volunteers, and advisors we pass along our thanks to this wonderful American Statesman as well as our sincere and heartfelt condolences to his family and loved ones.

Men's Health Network

Men's Health Network (MHN) is an international non-profit organization whose mission is to reach men, boys, and their families where they live, work, play, and pray with health awareness messages and tools, screening programs, educational materials, advocacy opportunities, and patient navigation. Learn more about MHN at www.MensHealthNetwork.org and follow them on Twitter @MensHlthNetwork and Facebook at www.facebook.com/menshealthnetwork . For more information on MHN's ongoing Dialogue on Men's Health series, visit www.DialogueOnMensHealth.com

Anne Di Gregory
Men's Health Network
+ +1 703-635-9416
email us here
Visit us on social media:

Source: EIN Presswire

IntuitiveX, WSMA, & US China Innovation Alliance Host COVID-19 Technology Innovation Summit

IntuitiveX, Washington State Medical Association, and US China Innovation Alliance bring together thousands of people for COVID-19 Technology Innovation Summit

SEATTLE, WASHINGTON, UNITED STATES, March 29, 2020 /EINPresswire.com/ — IntuitiveX, Washington State Medical Association, and US China Innovation Alliance are bringing together thousands of interested life science innovators, professionals, physicians, entrepreneurs, and investors together to attend the COVID-19 Technology Innovation Summit.

The purpose of the event is to bring together a global audience to discuss the recent innovations tackling the COVID-19 pandemic while providing an update on the current COVID-19 outbreak.

“As the epicenter of the COVID-19 outbreak in the U.S., Seattle, Washington serves as ground zero for this unprecedented national healthcare crisis. IntuitiveX, Washington State Medical Association, and U.S. China Innovation Alliance are partnering to host the first online COVID-19 Technology Innovation Summit to help facilitate the most up-to-date information from experts on the front lines and to feature innovative companies developing cutting-edge solutions to help combat this global pandemic.” Dr. Jeffrey Roh, CEO of IntuitiveX.

We will be joined by experts from the Center for Disease Control and Prevention (CDC), Washington State's Department of Health, the City of Seattle, Microsoft Healthcare, and early-stage COVID-19-related startups in an effort to share the innovative ways that Washington State—the epicenter of the U.S. viral outbreak—is taking action to solve COVID-19, one patient at a time.

For-profit companies ranging from startups to established multinational corporations and public health agencies ranging from local, regional, state and federal governments will be providing unique insights into how they are tackling the problem within their organizations and paving the way for innovative thinking to tackle the problems within their communities.

"No one would argue that today, we live in highly uncertain and historically unprecedented times. The worldwide effects of the COVID-19 global pandemic have permanently changed our lives forever. But it’s through challenging moments like these that we, as a society, are faced with a choice to either act passively and do nothing, or actively rally together to overcome the most critical healthcare crisis that our generation has faced in our lifetime." Dr. Jeffrey Roh, CEO of IntuitiveX.

The Agenda

4:00 PM: Global Healthcare Implications of the COVID-19 Pandemic — Jeff Roh, CEO of IntuitiveX
4:05 PM: COVID-19 Impact on U.S. Economy — Jun Hong, CFO & Strategist of IntuitiveX
4:10 PM: Q&A Panel

Public Health Agency Perspective

4:20 PM: Center for Disease Control & Prevention (CDC) — Diana Yassanye, Public-Private Partnerships
4:25 PM: Washington State Department of Health — Lacy Fehrenbach, MPH, CPH, Assistant Secretary, Prevention and Community Health
4:30 PM: King County — Executive Dow Constantine
4:35 PM: City of Seattle — Micheal Fong, Deputy Mayor of Seattle
4:40 PM: Evergreen Health (location of the first reported case of COVID-19 in Washington) — Ettore Palazzo, CMO of Evergreen Health
4:45 PM: Q&A Panel

Corporation Perspective

4:55 PM: Microsoft Healthcare — Desney Tan, Managing Director of Microsoft Healthcare & Chief Technologist at IntuitiveX
5:00 PM: Outdoor Research — Jason Duncan, VP of Tactical & Innovation of Outdoor Research
5:05 PM: Swedish Hospital — Jason Goldman, MD, MPH, Infectious Diseases, Swedish Hospital
5:10 PM: Q&A Panel

Startup Innovators

5:20 PM: Transpara Health — Susie Kataoka, CEO
5:25 PM: Arc Health — Nirav Shah and Ajay Gupta, Co-Founders
5:30 PM: Kinaptic — Joseph Curcio, COO
5:35 PM: Redoxagen — Craig Fryar, President & CEO, Torquin, LLC
5:40 PM: Pinpoint Sciences — Lisa Diamond, CEO
5:45 PM: Q&A Panel

5:55 PM: Closing Remarks & Announcements — Jeff Roh, CEO of IntuitiveX

The online, virtual summit will be held via a zoom conference – https://zoom.us/j/501381863 , and will be organized by IntuitiveX, Washington State Medical Association (WSMA), and the US China Innovation Alliance.

About: IntuitiveX is a life science consulting firm and incubator. With a team comprised of life science entrepreneurs, investors, and innovators, they bring a combined 100+ years of experience in R&D, Clinical, Surgical, IP Strategy, Prototyping, Product Development, and Commercialization. They catalyze medical innovation by removing the complexities, cost barriers, and time sensitivities related to introducing new products into the market. From initial concept to final commercialization, IntuitiveX has the in-house knowledge and network to meet the unique needs of the most innovative life science companies in the world. We’ve currently incubated more than 12+ portfolio companies and are always in search of more.

Website: www.intuitive-x.com

Tickets to the COVID-19 Technology Innovation Summit can be redeemed here: https://www.eventbrite.com/e/covid-19-technology-innovation-summit-tickets-101001269516

Emeka Alozie
+1 281-902-6391
email us here

Source: EIN Presswire

Prefabricated Modular Steel Panel Hospital Intensive Care Units (ICU's)

Intensive Care Units (ICU’s)

ICU Front View

Isolation Room with Negative Pressure HEPA Filtration & UV Light

Prefabricated Modular Steel Panel Hospital Intensive Care Units (ICU's) & Modular Isolation Rooms & Negative Pressure Rooms with HEPA Filter & UV Light Options

We have 330 million persons in the USA. In 12-18 months, 1% of the population (if tested) may be infected with COVID-19. If proper protocol is followed, millions of isolation units may be needed.””

— M.R. Secure Sales LLC Spokeman

MANALAPAN, NEW JERSEY, UNITED STATES, March 29, 2020 /EINPresswire.com/ — Panel Built has introduced Prefabricated Modular Steel Panel Hospital Intensive Care Units (ICU's) and Prefabricated Modular Hospital Isolation Rooms along with Negative Pressure Rooms, to help hospitals due to room shortages caused by the COVID-19 surge. Steel panel rooms have multiple uses and can be customized and adapted for for the individual hospital needs.
Panel Built, modular construction provider for 25 years, now offers a way for medical facilities to create and expand their infectious patient isolation areas with modular Isolation rooms. With the growing Coronavirus pandemic spreading across the United States and internationally, Panel Built’s modular isolation rooms are a convenient solution for hospitals that need to increase their single-occupancy, isolation space as quickly as possible. Using a panelized wall system, the isolation rooms are fully fabricated in Panel Built’s modular construction facilities. The components are then delivered and assembled on site. This design allows for prefabricated, quickly assembled isolation rooms that have fully customized layouts and designs.

Panel Built’s ICU's and isolation rooms offer options, (where situations warrant), for HVAC systems with fan filter units (FFUs) to keep the room at appropriate temperatures and constantly filter particles with HEPA filtration and UV light from the environment’s air supply with the numerous air exchanges per hour. Patient isolation rooms can be customized with a negative pressure environment for patients who may have an impaired immune system and may be a carrier for other infectious diseases that are airborne spread along with the droplet Coronavirus. Diseases such as TB, Measles, Mumps, Varicella and other respiratory infections fall into the airborne category. When the negative pressure isolation room is needed, the air pressure inside the isolation room is lower than entrance ante room to keep air flowing into the patient isolation room instead of out, keeping any contaminants or particles from escaping the room. All isolation rooms should be used in conjunction with proper staff and equipment sanitizing and hospital contamination control procedures.

Panel Built’s Steve Grzesik, Sales Manager Welded Steel Division, stated, "While Panel Built is a for-profit company, our first objective is to help our nation and others meet the challenge and help save lives. Our nation's largest hospitals and long term care centers will need all the isolation bed space they can get, and Panel Built is ready to help meet the need."

M.R. Secure Sales LLC spokesman stated the following, " There are 330 million persons in the USA. Predictions are, over the next 12-18 months, approximately 1% of the USA population (if tested) may be infected with the Coronavirus. If proper protocol is to be followed, millions of isolation rooms may be needed in the USA alone. The nations largest hospitals in total, may have fewer than several thousand isolation rooms. "
Panel Built was founded in 1995 by brothers Pat and Mike Kiernan, and began with the construction of pre-manufactured buildings. Today, Panel Built offers a complete line of custom modular offices, mezzanines, security booths, pre-assembled exterior buildings, and cleanrooms. Panel Built isolation rooms are designed 100% to customer specification and are delivered with components ready for installation. Panel Built’s main mission is, “Solving Our Customers’ Space Needs with Excellence and Great Customer Service.”

Isolation Room Brochure: https://www.panelbuilt.com/wp-content/uploads/Isolation-Rooms.pdf

For more information, visit: https://www.panelbuilt.com/isolation-rooms/


The New Generation in Modular Buildings, Enclosures & Mezzanines

Contact information:

Mike Rosenberg
M.R. Secure Sales
Limited Liability Company
Cell 732-491-5120

Steve Grzesik
Sales Manager Welded Steel Division,

Panel Built, Inc.
P.O. Box 2658, Blairsville, GA 30514
Office (706) 745-6540 TF (800) 636-3873 Fax (706) 745-1450

“M.R. Secure Sales LLC represents leaders in Modular Prefabricated Modular Steel Panel Hospital Intensive Care Units (ICU's) Isolation rooms and Negative Pressure Infectious Disease Isolation Rooms,Clean Rooms,Guard/Security/Parking Booths & Bus Shelters, Offsite Sustainable Construction of Steel and Concrete Multi-Story Modular Schools, Dorms, Condos, Town Houses, Senior Housing, Hotels, Retail Stores, Emergency Care Facilities, Equipment/Telecommunication Shelters, Modular Correctional Facilities, Modular Steel Police/Jail and Prison Cells,Modular Offices within in Factories and Warehouses, and Miscellaneous Metals and Custom Steel Railings and Stairs”

+1 732-491-5120
email us at mrosenberg@mrsecuresales.com
Visit us on social media:
Michael J Rosenberg
+1 732-491-5120

Michael J Rosenberg
+1 732-491-5120
email us here
Visit us on social media:

Source: EIN Presswire

Vitro Biopharma First Quarter ended January 31st 2020 Financial Results of Operations

Vitro Biopharma is pleased to announce a record 1st comparative quarter in Total Revenues of $225,921 vs $192,895 an increase of 17% versus last year.

Vitro Diagnostics Inc. (OTCMKTS:VODG)

Vitro is pleased to have recently been recognized by Bioinformant as "a Company Tracking the Coronavirus".

— Dr. James Musick

GOLDEN, CO, USA, March 28, 2020 /EINPresswire.com/ — Vitro Biopharma First Quarter ended January 31st 2020 Financial Results of Operations

Golden, Colorado-March 26, 2020-Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma, announced its 1st quarter ended January 31st, 2020 financial results of operations.

Vitro Diagnostics Inc. (“Vitro Biopharma”) is pleased to announce a record 1st comparative quarter in Total Revenues. Vitro Biopharma recorded 1st quarter revenues of $225,921 vs $192,895 an increase of 17% over the same comparative quarter last year. In addition, Stem Cell treatments accounted for 74% of the revenues up from 71% of the revenues in the prior comparative quarter last year. Current quarter stem cell revenues were $167,750 for the 1st quarter ended January 31, 2020 vs $137,123 for the first quarter ended January 31, 2019.

The company’s gross profit margins improved to 75% up from 73% in the comparative prior year’s quarter. Gross margin improvement is in line with the strategic direction of the company to expand the market of its flagship product AlloRx™ Stem Cells. The company’s clean-room lab expansion last year and expanded Stem Cell manufacturing using its patent-pending cell line, has increased efficiencies and lowered production costs.

Overall operating expenses increased in the quarter to $193,385 from $147,398 in the prior year’s comparative quarter. The increase in expenses reflects additional investment as the Company expands its capability to service its strategic direction of offshore Stem Cell treatments while also expanding into US markets. The company expended additional resources on external consultants supporting our regulatory status in maintaining ISO9001 & ISO13485 certifications, expanding our efforts to approach US markets through FDA filings and advancement of existing patent filings.

The company’s first quarter is its most seasonal quarter as the period between Thanksgiving and the New Year is slow for all the company’s revenue lines of Nutra Vivo™/STEMulize, AlloRx™ Stem Cells, private labeled InfiniVive MD™ Stem Cell Serum and our core research products.

During the quarter the company achieved and pursed the following company objectives

• Series A Convertible Preferred Stock Offering:

During the quarter the company commenced a Series A Convertible Preferred Stock offering to accredited investors under the SEC Regulation D exemption. The preferred Stock is priced at $25 per share which is convertible at $0.25 cents per share for a total of 100 shares. The minimum investment is $50,000 per unit. The company sold $450,000 of the Series A Convertible Preferred Stock during the quarter. The company has additional interest in the offering and subsequent to the quarter has sold an additional $50,000 unit for a total to date of $500,000. The company has additional interested parties for approximately $200,000. The offering is for a total of $1,000,000.

• Expansion of revenues & results from the clinical trials in the Cayman Islands:

Our partnership with DVCStem in the Cayman Islands continued to advance through treatment of new & previous patients. This IRB-approved protocol targets patients with inflammatory conditions including multiple sclerosis, systemic inflammation and new indications including Crohn's disease, Alzheimer’s disease and COPD. To date we have treated 60 patients including repeat treatments. There have been no serious adverse events and we continue to gain evidence of efficacy. One of the initial MS patients has now received a second transplant of our AlloRx™ Stem Cells and he has reported significant therapeutic benefits of both the initial and subsequent therapy. He had received an earlier transplant of adipose-derived MSCs that was effective, but the improvement lasted 3 months while AlloRx™ Stem Cell therapy lasted 18 months. We had predicted such a clinical outcome based on significantly higher potency of umbilical cord MSCS compared to those derived from adipose tissue or bone marrow. The Crohn’s disease patient showed significant improvement as did both the AD & COPD patients.

• Further Expansion into US Markets-FDA IND:

The strategic development of our stem cell therapies involves pursuit of both offshore and domestic markets. The partnership with DVC Stem, our IRB-approved trial in the Bahamas together with other strategic opportunities represent offshore operations & prospects. During Q1 2020, we initiated expansion into US therapeutic markets through development of an Investigational New Drug (IND) application for submission to FDA. Once approved, an IND allows the conduct of clinical trials for specific medical conditions in the US.

Given the current COVID-19 pandemic, our initial IND application is for use of AlloRx™ Stem Cells in treatment of Coronavirus infections. This is supported by clinical studies showing that 17 critically ill patients responded favorably to IV infusion of umbilical cord-derived MSCs. All patients were receiving assisted ventilation but 3 days following stem cell therapy, were removed from ventilators and subsequently discharged from the hospital. We are pursuing discussions with FDA to establish the appropriate regulatory pathway and expedited review options given the current emergency circumstances. (See Subsequent Events, below, for additional discussion of our COVID-19 response.) Once our initial IND is in place, we have plans for additional INDs for stem cell therapy of musculoskeletal conditions and Alzheimer’s disease.

• PR Medica Opportunity:

We have received an initial order of AlloRx™ Stem Cells for testing purposes by PR Medica located in Cabo San Lucas. Given successful test results, we anticipate subsequent new revenue generation from this customer.

• InfiniVive MD™ Stem Cell Serum:

Vitro Biopharma’s cosmetic topical stem cell serum is being distributed by InfiniVive MD™ into cosmetic clinics that are providing the topical treatment as a beautification product. To date the company’s product is being offered in 10 cosmetic clinics.

Our partner, Dr Jack Zamora, MD was a keynote speaker at a master session at the American Academy of Cosmetic Surgery annual meeting in late February. The topic of his presentation was “Topical Stem Cells, Exosomes and Conditioned Media Serums in Aesthetics.” This was the official launch of the InfiniVive-MD platform including: Dailey Serum, Stem Cell Serum 2.0 & Exosomes within the product line. Vitro Biopharma will manufacture & private label these new products for distribution in the US. We anticipate InfiniVive MD growth, development and revenues to mirror the development of Apyx subdermal plasma skin tightening as a cosmetic treatment and technique that has gone global.

www.jackzamoramd.com www.infinivivemd.com

• Research and Development, Facility Expansion & Patent Prosecution

Our core research product sales continued to expand in Q1 2020. Our facility expansion continued with addition of manufacturing capacity and development of plans to add operational facility to increase outputs further by 100% or more. We were also in discussions with the USPTO regarding our pending patents for our novel stem cell therapy and stem cell activation technology. We continue to work closely with our examiner and have established communication channels to facilitate awards of these patents.

• SUBSEQUENT EVENTS: COVID-19 Opportunity and Risks

The COVD-19 pandemic is a significant obstacle for all business. However, Vitro Biopharma is uniquely positioned since we have a potential effective therapy. This is based on 3 independent reports showing efficacy of stem cell therapy in 17 COVID-19 patients. All were treated with IV umbilical cord MSCs comparable to AlloRx™ Stem Cells and all 17 required respiratory assistance but within 3-4 days of treatment, were able to breath without ventilators and were discharged within 14 days. https://www.scmp.com/news/china/society/article/3053080/coronavirus-critically-ill-chinese-patient-saved-stem-cell On the contrary, untreated patients on ventilators have death rates of 50% or more. We have received a formal request to supply AlloRx™ Stem Cells for compassionate use from a major university medical center and several other potential clinical partners have also expressed interest in using our cells to treat COVID-19 patients. We are presently working with the FDA to gain authority to begin clinical testing in the US. We are currently assessing the overall financial impact of the COVID-19 pandemic on our business, but this depends on overall control of the pandemic. There have been no staff layoffs and our workers are considered essential since we conduct essential research to the COVID-19 response.

Dr. Jim Musick, CEO of Vitro Biopharma, said, “We are very pleased with the increased revenue growth during our first quarter 2020 compared to the prior year However all our resources are currently focused on the emergency response to the COVID-19 pandemic and increasing our inventory of AlloRx to satisfy anticipated emergency demand to treat critically ill COVID-19 patients.” The Company is working to get expedited clinical trial approvals to sell our AlloRx Stem Cells to hospitals coping with the pandemic. Vitro is pleased to have recently been recognized by Bioinformant as "a Company Tracking the Coronavirus".
https://bioinformant.com/product/coronavirus-covid-19-report/ We anticipate clinical progress in the effectiveness of our stem cell therapies while expecting to see a reduction in our offshore and cosmetic revenues for the next quarter or two. The company is in a good cash position to weather this storm and simultaneously advance its AlloRx stem cell therapies into clinical trials.

In summary, Vitro Biopharma is advancing as a key player in regenerative medicine with 10+years’ experience in the development and commercialization of stem cell products for research, recognized by a Best in Practice Technology Innovation Leadership award for Stem Cell Tools and Technology and a growing track record of successful translation to therapy. We are leveraging our proprietary technology platform to the establishment of international Stem Cell Centers of Excellence and regulatory approvals in the US and worldwide.

Sincerely yours,

James R. Musick, PhD.
President, CEO & Chairman of the Board

Forward-Looking Statements

Statements herein regarding financial performance have not yet been reported to the SEC nor reviewed by the Company’s auditors. Certain statements contained herein and subsequent statements made by and on behalf of the Company, whether oral or written may contain “forward-looking statements”. Such forward looking statements are identified by words such as “intends,” “anticipates,” “believes,” “expects” and “hopes” and include, without limitation, statements regarding the Company’s plan of business operations, product research and development activities, potential contractual arrangements, receipt of working capital, anticipated revenues and related expenditures. Factors that could cause actual results to differ materially include, among others, acceptability of the Company’s products in the market place, general economic conditions, receipt of additional working capital, the overall state of the biotechnology industry and other factors set forth in the Company’s filings with the Securities and Exchange Commission. Most of these factors are outside the control of the Company. Investors are cautioned not to put undue reliance on forward-looking statements. Except as otherwise required by applicable securities statutes or regulations, the Company disclaims any intent or obligation to update publicly these forward-looking statements, whether as a result of new information, future events or otherwise.

Dr. James Musick
Chief Executive Officer
Vitro BioPharma
(303) 999-2130 Ext. 3
E-mail: jim@vitrobiopharma.com

Source: Vitro Diagnostics, Inc.



John Evans
Vitro BioPharma
+1 303-601-7855
email us here

Source: EIN Presswire